Literature DB >> 25013011

Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?

Maria A Baturova1, Arne Lindgren2, Jonas Carlson3, Yuri V Shubik4, S Bertil Olsson3, Pyotr G Platonov3.   

Abstract

AIMS: Data from national discharge registers are commonly used to estimate prevalence and incidence of atrial fibrillation (AF) in epidemiology studies. However, sensitivity and specificity of register-based AF diagnosis have not been evaluated. We sought to assess the validity of AF diagnosis in the Swedish Patient Register against electrocardiography (ECG) documentation of AF. METHODS AND
RESULTS: The study sample comprised of 336 patients [median age 76 (interquartile range (IQR) 67-82 years, 136 female] with first-ever ischaemic stroke, enroled in the Lund Stroke Register from March 2001 to February 2002 and 1 : 1 age- and gender-matched control subjects without stroke from the population register. Data was exported from the patient register in October 2011 (the end of follow-up). Atrial fibrillation documentation by ECG was assessed using an electronic archive containing all ECGs taken in the hospital catchment area starting in 1988. A total of 7247 ECGs were reviewed, with the median number of ECGs per person being 7.5 (IQR 3-15). Atrial fibrillation was detected by ECG in 190 patients; and in 188 patients by linkage with patient register. In most patients, AF was documented first by ECG data, with median time to register diagnosis being 16 days (IQR 3-859). Specificity of AF diagnosis in the Swedish Patient Register was 93%, sensitivity was 80%.
CONCLUSION: Despite the high specificity, AF diagnosis in the Swedish Patient Register assessed in the population of ischaemic stroke patients and age- and gender-matched control subjects has modest sensitivity, which may result in underestimating prevalent and incident AF cases if only register data are used for identification of subjects with AF in epidemiology studies. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Electrocardiography; Sensitivity; Specificity; Swedish Patient Register; Validity

Mesh:

Year:  2014        PMID: 25013011     DOI: 10.1093/europace/euu165

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study.

Authors:  Kasper Andersen; Finn Rasmussen; Claes Held; Martin Neovius; Per Tynelius; Johan Sundström
Journal:  BMJ       Date:  2015-09-16

2.  Atrial time and voltage dispersion are both needed to predict new-onset atrial fibrillation in ischemic stroke patients.

Authors:  Daniel Cortez; Maria Baturova; Arne Lindgren; Jonas Carlson; Yuri V Shubik; Bertil Olsson; Pyotr G Platonov
Journal:  BMC Cardiovasc Disord       Date:  2017-07-24       Impact factor: 2.298

3.  Sensitivity, specificity, positive and negative predictive values of identifying atrial fibrillation using administrative data: a systematic review and meta-analysis.

Authors:  Ren Jie Robert Yao; Jason G Andrade; Marc W Deyell; Heather Jackson; Finlay A McAlister; Nathaniel M Hawkins
Journal:  Clin Epidemiol       Date:  2019-08-23       Impact factor: 4.790

4.  Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.

Authors:  Jonatan Jacobsson; Christian Reitan; Jonas Carlson; Rasmus Borgquist; Pyotr G Platonov
Journal:  BMC Cardiovasc Disord       Date:  2019-08-13       Impact factor: 2.298

5.  Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.

Authors:  Jun Xiao; Anders P Persson; Gunnar Engström; Linda S B Johnson
Journal:  BMC Cardiovasc Disord       Date:  2021-03-12       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.